| Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG) (NCT00953121) | Annick Desjardins | 2009-09-01 |
| Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide (NCT00900757) | Duke University | 2009-08-01 |
| Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme (NCT00919737) | Nobelpharma | 2009-06-01 |
| LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma (NCT00859222) | Patrick Y. Wen, MD | 2009-03-01 |
| A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) (NCT00735436) | Duke University | 2008-12-01 |
| Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma (NCT00782756) | Memorial Sloan Kettering Cancer Center | 2008-10-28 |
| A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas (NCT00766467) | Eudocia Quant Lee, MD | 2008-09-01 |
| A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma (NCT00683761) | TransMolecular | 2008-08-01 |
| Study of Capecitabine to Treat Recurrent High Grade Gliomas (NCT00717197) | University of Florida | 2008-07-01 |
| Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over (NCT02892708) | Assistance Publique - Hôpitaux de Paris | 2008-04-01 |
| Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma (NCT00591058) | TransMolecular | 2008-02-01 |
| Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme (NCT00458601) | Celldex Therapeutics | 2007-08-01 |
| Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients (NCT00576446) | Cedars-Sinai Medical Center | 2007-04-01 |
| Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma (NCT00589875) | Candel Therapeutics, Inc. | 2007-03-01 |
| Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas (NCT00766753) | Frank Lieberman | 2006-12-01 |
| Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas (NCT00528684) | Oncolytics Biotech | 2006-07-01 |
| Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas (NCT00751270) | Candel Therapeutics, Inc. | 2005-11-01 |
| G207 Followed by Radiation Therapy in Malignant Glioma (NCT00157703) | MediGene | 2005-05-01 |
| Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy (NCT00125697) | AHS Cancer Control Alberta | 2005-05-01 |
| 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma (NCT00114309) | TransMolecular | 2004-11-01 |
| Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) (NCT00087451) | Merck Sharp & Dohme LLC | 2004-07-01 |
| Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases (NCT00103038) | OHSU Knight Cancer Institute | 2004-06-04 |
| Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma (NCT00064779) | INSYS Therapeutics Inc | 2003-07-01 |
| Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors (NCT00075387) | OHSU Knight Cancer Institute | 2003-03-07 |
| A Study of LY317615 in Patients With Brain Tumors (NCT00190723) | Eli Lilly and Company | 2002-10-01 |
| This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma. (NCT00032903) | Sigma-Tau Research, Inc. | 2002-03-01 |
| High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma (NCT00283556) | Kentuckiana Cancer Institute | 2001-08-01 |
| Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients (NCT00024557) | INSYS Therapeutics Inc | 2001-06-01 |
| Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma (NCT00024570) | INSYS Therapeutics Inc | 2000-11-01 |
| Comparative 2-D Tumor Analysis in Familial Gliomas (NCT00125710) | AHS Cancer Control Alberta | 1998-06-01 |
| MK-2206 for Recurrent Malignant Glioma (NCT01249105) | Dana-Farber Cancer Institute | |
| Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients (NCT01952886) | Duke University | |